Last updated: December 15, 2025
Sponsor: Rush University Medical Center
Overall Status: Active - Not Recruiting
Phase
3
Condition
Infertility
Erectile Dysfunction
Male Hormonal Deficiencies/abnormalities
Treatment
Chlorhexidine
Gentamicin
Rifampin
Clinical Study ID
NCT06489431
21120903
Male Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Inclusion criteria include all men undergoing penile prosthesis (any manufacturer)implantation (inpatient or outpatient)
Exclusion
Exclusion Criteria:
- Exclusion criteria include men who are having revision implant surgeries, men whomay require intraoperative complex reconstruction including graft for Peyronie'sDisease, and transgender males
Study Design
Total Participants: 200
Treatment Group(s): 3
Primary Treatment: Chlorhexidine
Phase: 3
Study Start date:
December 04, 2023
Estimated Completion Date:
December 31, 2027
Study Description
Connect with a study center
Urological Surgeons of Northern California
Mountain View 5375480, California 5332921 94035
United StatesSite Not Available
Rush University Medical Center
Chicago, Illinois 60612
United StatesSite Not Available
Uropartners Surgery Center
Des Plaines, Illinois 60018
United StatesSite Not Available
Rush University Medical Center
Chicago 4887398, Illinois 4896861 60612
United StatesSite Not Available
Uropartners Surgery Center
Des Plaines 4889772, Illinois 4896861 60018
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.